SPONSOR
Yunnan Cancer Hospital
Total Trials
4
Recruiting
4
Phases
N/A
Conditions studied: Lung CancerBreast Cancer MetastaticSentinel Lymph NodeSentinel Lymph Node Biopsy (SLNB)MetastasisNon-Alcoholic Fatty Liver DiseaseBreast Cancer
Yunnan Cancer Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Lung Cancer, Breast Cancer Metastatic, Sentinel Lymph Node, Sentinel Lymph Node Biopsy (SLNB).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Yunnan Cancer Hospital
How many clinical trials has Yunnan Cancer Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Yunnan Cancer Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Lung Cancer, Breast Cancer Metastatic, Sentinel Lymph Node. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Yunnan Cancer Hospital research focus on?
Yunnan Cancer Hospital clinical trials span Lung Cancer, Breast Cancer Metastatic, Sentinel Lymph Node, Sentinel Lymph Node Biopsy (SLNB), Metastasis, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Yunnan Cancer Hospital clinical trial?
To participate in a Yunnan Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yunnan Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Yunnan Cancer Hospital
NCT06742021
Recruiting
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
Lung Cancer
NCT07154563
Recruiting
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
Breast Cancer Metastatic
NCT06735118
Recruiting
Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
Non-Alcoholic Fatty Liver Disease
NCT06495736
Recruiting
Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology